Kursprognose für BioVie Inc (BIVI)BIVIBioVie Inc

Alphio's BIVI stock price prediction model matches the current BioVie Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.32 (-1.44%). The 1-week path is $1.31 (-2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

BioVie Inc. is currently priced at $1.34, which is significantly below its 52-week high of $3.79, indicating potential for recovery. However, the company has reported a consistent negative net income, with the latest quarterly loss at $5,270,299. The RSI is at 47.41, suggesting the stock is neither overbought nor oversold. Given the recent positive news about the Phase 2 trial results for Bezisterim, which showed significant improvements in neurological symptoms associated with Long COVID, there is potential for future growth. However, the stock's recent performance shows a 5-day decline of 6.29%, indicating volatility. Therefore, while there are promising developments, the ongoing losses and recent price drop suggest that holding may be the best strategy for now.

BioVie Inc (BIVI) last closed at $1.34, gaining +10.74%. These facts feed the 1-day and 1-week BIVI price prediction above.